Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial Coall 08-09

Gabriele Escherich, MD, Udo Zur Stadt, PhD, Dagmar Dilloo, MD, Joerg Faber, MD PhD, Tobias Feuchtinger, MD, Thomas Imscheiler, MD, Norbert Jorch, MD, Arnulf Pekrun, Irene Schmid, MD, Martin Zimmermann, PhD, Martin A. Horstmann, MD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-136149

Published: 2020

Journal Articles

Amsacrine, Etoposide and Methylprednisolone As Part of the Therapy Intensification in Children with Acute Lymphoblastic Leukemia: A Retrospective Analysis in the Trial Coall 08-09

Gabriele Escherich, Katharina Wos, MD, Franziska Schramm, MD, Martin A. Horstmann, MD

Blood (2018) 132 (Supplement 1): 5168.

https://doi.org/10.1182/blood-2018-99-112623

Published: 2018

Journal Articles

TIM-3 Expression on CD4 + Bone Marrow T Cells Predicts Relapse of Pediatric B-Precursor Acute Lymphoblastic Leukemia

Franziska Blaeschke, MD, Semjon Willier, MD, Dana Stenger, Mareike Lepenies, Martin A. Horstmann, MD, Gabriele Escherich, Martin Zimmermann, PhD, Theresa Kaeuferle, PhD, Meino Rohlfs, PhD, Irene Schmid, MD, Michael H. Albert, MD, Vera Binder, MD, Christoph Klein, MD PhD, Tobias Feuchtinger, MD

Blood (2018) 132 (Supplement 1): 2833.

https://doi.org/10.1182/blood-2018-99-118376

Published: 2018

Journal Articles

Rapid Capture NGS Identifies Genomic Rearrangements in BCP-ALL for MRD Diagnostics

Udo Zur Stadt, PhD, Malik Alawi, M. Sc., Gabriele Escherich, MD, Martin A. Horstmann, MD

Blood (2017) 130 (Supplement 1): 2715.

https://doi.org/10.1182/blood.V130.Suppl_1.2715.2715

Published: 2017

Journal Articles

Daunorubicin during Delayed Intensification Considerably Lowers the Incidence of Infectious Complications but Might Result in Decreased Disease-Free Survival Compared to Adriamycin in Children with Acute Lymphoblastic Leukemia - a Randomized Comparison in Trial Coall 08-09.

Gabriele Escherich, MD, Franziska Schramm, MD, Martin Zimmermann, PhD, Martin A. Horstmann, MD

Blood (2017) 130 (Supplement 1): 2599.

https://doi.org/10.1182/blood.V130.Suppl_1.2599.2599

Published: 2017

Journal Articles

JAK2 Aberrations in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

Elisabeth M.P. Steeghs, MSc, Isabel S. Jerchel, MSc, Willemieke de Goffau-Nobel, MSc, Alex Q. Hoogkamer, BSc, Judith M. Boer, PhD, Aurélie Boeree, BSc, Cesca van de Ven, PhD, Marco J. Koudijs, PhD, Nicolle J.M. Besselink, BSc, Hester A. de Groot-Kruseman, PhD, C. Michel Zwaan, MD PhD, Martin A. Horstmann, MD, Rob Pieters, MD PhD, Monique L. Den Boer, PhD

Blood (2016) 128 (22): 583.

https://doi.org/10.1182/blood.V128.22.583.583

Published: 2016

Journal Articles

RAS Pathway Mutations As Predictive Biomarker for Treatment Adaptation in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Isabel S. Jerchel, MSc, Alex Q. Hoogkamer, BSc, Ingrid M. Ariës, PhD, Elisabeth M.P. Steeghs, MSc, Judith M. Boer, PhD, Nicolle J.M. Besselink, BSc, Aurélie Boeree, BSc, Cesca van de Ven, PhD, Hester A. de Groot-Kruseman, PhD, Valerie De Haas, MD PhD, Martin A. Horstmann, MD, Gabriele Escherich, MD, Ronald W. Stam, PhD, C. Michel Zwaan, MD PhD, Edwin Cuppen, PhD, Marco J. Koudijs, PhD, Rob Pieters, MD PhD, Monique L. Den Boer, MSc, PhD

Blood (2016) 128 (22): 4087.

https://doi.org/10.1182/blood.V128.22.4087.4087

Published: 2016

Journal Articles

Constitutive Activation of FLT3 Is a Positive Prognostic Factor in Infants with MLL-Rearranged Acute Lymphoblastic Leukemia

Henning Fedders, PhD, Denis Martin Schewe, MD, Martin Zimmermann, PhD, Ameera Alsadeq, PhD, Anja Moericke, MD, Udo zur Stadt, PhD, Martin A. Horstmann, MD, Rob Pieters, MD PhD, Martin Schrappe, MD PhD, Gunnar Cario, MD, Martin Stanulla, MD

Blood (2015) 126 (23): 1417.

https://doi.org/10.1182/blood.V126.23.1417.1417

Published: 2015

Journal Articles

Rapid Capture Targeted Next Generation Sequencing (NGS) for Detection of Genomic Kinase- and Cytokine-Receptor Rearrangements in B-Precursor Acute Lymphoblastic Leukemia

Gabriele Escherich, MD, Udo zur Stadt, PhD, Malik Alawi, Martin A. Horstmann, MD

Blood (2015) 126 (23): 2609.

https://doi.org/10.1182/blood.V126.23.2609.2609

Published: 2015

Journal Articles

Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study

Blood (2014) 124 (21): 368.

https://doi.org/10.1182/blood.V124.21.368.368

Published: 2014

Journal Articles

Epigenetic Dysregulation Of ZNF423 Impedes B-Cell Differentiation and Is Linked To Adverse Outcome Of Childhood B-Precursor ALL

Ann-Christin Puller, MSc, Lena Harder, PhD, Martin Zimmermann, PhD, Carol Stocking, PhD, Martin A. Horstmann, MD

Blood (2013) 122 (21): 3745.

https://doi.org/10.1182/blood.V122.21.3745.3745

Published: 2013

Journal Articles

BCR-ABL1 -Like Cases In Pediatric Acute Lymphoblastic Leukemia: A Comparison Between COG/St. Jude and Dutch DCOG Signatures

Judith M. Boer, PhD, João R.M. Marchante, MSc, Martin A. Horstmann, MD, Gabriele Escherich, MD, William E. Evans, PharmD, Rob Pieters, MD, PhD, Monique L. Den Boer

Blood (2013) 122 (21): 2633.

https://doi.org/10.1182/blood.V122.21.2633.2633

Published: 2013

Journal Articles

Key Nodes In FLT3 Dependent Signaling Determine Growth and Survival Of Childhood Acute Lymphoblastic Leukemia

Kevin Dierck, PhD, Ina Siekmann, MSc, Sebastian Prall, PhD, Florian Beck, MSc, Irmela Jeremias, MD, Albert Sickmann, PhD, Martin A. Horstmann, MD

Blood (2013) 122 (21): 2508.

https://doi.org/10.1182/blood.V122.21.2508.2508

Published: 2013

Journal Articles

EMP1, a Novel Poor Prognostic Factor In Pediatric Leukemia Regulates Prednisolone Resistance, Cellular Proliferation, Migration and Adhesion

Ingrid M. Ariës, MSc, Rosanna van den Dungen, BASc, Isabel S. Jerchel, MSc, Lieke C. van den Berk, PhD, Judith M. Boer, PhD, Martin A. Horstmann, MD, Gabriele Escherich, MD, Rob Pieters, Monique L. Den Boer

Blood (2013) 122 (21): 616.

https://doi.org/10.1182/blood.V122.21.616.616

Published: 2013

Journal Articles

Highly Sensitive Bioluminescence in Vivo Imaging Enables Individualized Preclinical Treatment Trials On Patients ALL Tumor Cells Growing in Mice.

Nadia Terziyska, Catarina Castro Alves, Manfred Ogris, Ernst Wagner, Renier J Brentjens, MD, PhD, Martin A. Horstmann, MD, Leticia Quintanilla-Martinez, MD, PhD, Irmela Jeremias, MD

Blood (2012) 120 (21): 2602.

https://doi.org/10.1182/blood.V120.21.2602.2602

Published: 2012

Journal Articles

Clofarabine in the Frontline Treatment of Childhood Acute Lymphoblastic Leukemia. Results of the COALL 08–09 Study Regarding Safety and Efficacy of Clofarabine in Combination with Asparaginase During Consolidation Therapy.

Gabriele Escherich, MD, Martin Zimmermann, PhD, Martin A. Horstmann, MD

Blood (2012) 120 (21): 2606.

https://doi.org/10.1182/blood.V120.21.2606.2606

Published: 2012

Journal Articles

Identification of a Novel T-ALL Entity with NKX2-1/NKX2-2 Rearrangements

Blood (2010) 116 (21): 3139.

https://doi.org/10.1182/blood.V116.21.3139.3139

Published: 2010

Journal Articles

MEF2C as Novel Oncogene for Early T-Cell Precursor (ETP) Leukemia

Blood (2010) 116 (21): 9.

https://doi.org/10.1182/blood.V116.21.9.9

Published: 2010

Journal Articles

PTEN/AKT Pathway Mutations Are Reciprocal to NOTCH-Activating Mutations In Pediatric T-Cell Acute Lymphoblastic Lymphoma (T-ALL)

Linda Zuurbier, L, Maartje Vuerhard, Clarissa Kooi, Willem K Smits, W.K., Jessica Buijs-Gladdines, Martin A. Horstmann, MD, Válerie de Haas, MD, PhD, Rob Pieters, MD, PhD, Jules Meijerink, PhD

Blood (2010) 116 (21): 1710.

https://doi.org/10.1182/blood.V116.21.1710.1710

Published: 2010

Journal Articles

In-Vitro Efficacy of the Deoxyguanoside Analogs Forodesine (BCX- 1777) and ARA-G in Pediatric Acute Lymphoblastic Leukemia Cells.

Irene Homminga, MD, Christian M Zwaan, MD, PhD, Chantal Y. Manz, PhD, Shanta Bantia, PhD, Cynthia Parker, Jessica Buijs-Gladdines, Wilco Smits, Martin A. Horstmann, MD, Rob Pieters, MD, PhD, Jules P.P. Meijerink, MSc, PhD

Blood (2008) 112 (11): 1925.

https://doi.org/10.1182/blood.V112.11.1925.1925

Published: 2008

NARROW

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial Coall 08-09

Amsacrine, Etoposide and Methylprednisolone As Part of the Therapy Intensification in Children with Acute Lymphoblastic Leukemia: A Retrospective Analysis in the Trial Coall 08-09

TIM-3 Expression on CD4 + Bone Marrow T Cells Predicts Relapse of Pediatric B-Precursor Acute Lymphoblastic Leukemia

Rapid Capture NGS Identifies Genomic Rearrangements in BCP-ALL for MRD Diagnostics

Daunorubicin during Delayed Intensification Considerably Lowers the Incidence of Infectious Complications but Might Result in Decreased Disease-Free Survival Compared to Adriamycin in Children with Acute Lymphoblastic Leukemia - a Randomized Comparison in Trial Coall 08-09.

JAK2 Aberrations in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

RAS Pathway Mutations As Predictive Biomarker for Treatment Adaptation in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Constitutive Activation of FLT3 Is a Positive Prognostic Factor in Infants with MLL-Rearranged Acute Lymphoblastic Leukemia

Rapid Capture Targeted Next Generation Sequencing (NGS) for Detection of Genomic Kinase- and Cytokine-Receptor Rearrangements in B-Precursor Acute Lymphoblastic Leukemia

Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study

Epigenetic Dysregulation Of ZNF423 Impedes B-Cell Differentiation and Is Linked To Adverse Outcome Of Childhood B-Precursor ALL

BCR-ABL1 -Like Cases In Pediatric Acute Lymphoblastic Leukemia: A Comparison Between COG/St. Jude and Dutch DCOG Signatures

Key Nodes In FLT3 Dependent Signaling Determine Growth and Survival Of Childhood Acute Lymphoblastic Leukemia

EMP1, a Novel Poor Prognostic Factor In Pediatric Leukemia Regulates Prednisolone Resistance, Cellular Proliferation, Migration and Adhesion

Highly Sensitive Bioluminescence in Vivo Imaging Enables Individualized Preclinical Treatment Trials On Patients ALL Tumor Cells Growing in Mice.

Clofarabine in the Frontline Treatment of Childhood Acute Lymphoblastic Leukemia. Results of the COALL 08–09 Study Regarding Safety and Efficacy of Clofarabine in Combination with Asparaginase During Consolidation Therapy.

Identification of a Novel T-ALL Entity with NKX2-1/NKX2-2 Rearrangements

MEF2C as Novel Oncogene for Early T-Cell Precursor (ETP) Leukemia

PTEN/AKT Pathway Mutations Are Reciprocal to NOTCH-Activating Mutations In Pediatric T-Cell Acute Lymphoblastic Lymphoma (T-ALL)

In-Vitro Efficacy of the Deoxyguanoside Analogs Forodesine (BCX- 1777) and ARA-G in Pediatric Acute Lymphoblastic Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only